The Tumor Models series enables the preclinical oncology community to come together and uncover emerging next generation models that will enhance their preclinical strategies. Tumor Models Boston 2015 became a unique focal point for the preclinical and translational community seeking to improve their pre-clinical predictions and discover the right modeling platforms to translate efficacy into approval therapies.